Sistem PatentSistem Patent
Menu
European Patent (TR Translation)

Modifiye Tüberküloz Antijenleri.

Invention Abstract

Modifiye Rv3616c proteinleri ve bunların özellikle tüberküloz reaktivasyonunu önlenmek için ilaçlar olarak kullanımı.

IPC Classes
C07K 14/35A61K 39/04
Parties
Inventor
Normand Blaıs Id Biomedical Corporation Of Quebec 525 Cartier Boulevard West Laval, Quebec H7v 3s8 Kanada James Brown Glaxosmithkline 1250 South Collegeville Road Po Box 5089 Collegeville, Pennsylvania 19426 A.B.D. Dennıs Murphy C/O Glaxosmithkline 1250 South Collegeville Road Po Box 5089 Collegeville, Pennsylvania 19426 A.B.D. Pascal Mettens Glaxosmithkline Biologicals S.A. Rue De L'ınstitut 89 B- 1330 Rixensart Belçika Anne-Marıe Gelınas Id Biomedical Corporation Of Quebec 525 Cartier Boulevard West Laval, Quebec H7v 3s8 Kanada
Rights Holder
Glaxosmıthklıne Bıologıcals S.A. Rue De L'ınstitut, 89 1330 Rixensart Belçika Glaxo Group Lımıted 980 Great West Road Brentford, Middlesex Tw8 9gs İngiltere
Attorney
Mehmet Nazım Aydın Deriş (Deriş Patent Ve Marka Acentalığı A.Ş.) İnebolu Sok. Deriş Patent Binası No:5 Kabataş/ Setüstü 80040/İstanbul

This record is compiled from official TPMK patent bulletins and is provided for information. The abstract text is as published, in Turkish. The current legal status (opposition, assignment, invalidation) requires a full register review. Ask our experts for a comprehensive patent search.